(Q85906573)
Statements
DPP-4 Inhibitor Teneligliptin Improves Insulin Resistance and Serum Lipid Profile in Japanese Patients with Type 2 Diabetes (English)
M Kusunoki
D Sato
T Nakamura
Y Oshida
H Tsutsui
Y Natsume
K Tsutsumi
4 November 2014